CClinicalTrials.gg
Status unknownNCT01025011Updated Dec 3, 2009

Non-invasive Measurement of Hemoglobin in Retinal Arteries

An observational study in Healthy Subjects and Anemia, sponsored by Triemli Hospital. Status unknown at 1 site in Switzerland. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-12-03.

Sponsored by Triemli Hospital · Observational

The sponsor has not verified this record recently (last verified Nov 2009), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Enrollment
100
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The purpose of this study is to test a new non-invasive tool to measure hemoglobin in retinal arteries.

Read the detailed description

To our knowledge no tool exists that allows for direct collection of hemoglobin data in the eye. In many eye diseases (especially diabetic and hypertensive retinopathy as well as in retinal vessel occlusions) retinal circulation is modified. Knowing hemoglobin concentration on the site of the pathology will give us further information about the pathogenesis of this diseases and may provide a new possibility in therapy.

The purpose of this study is to test a new non-invasive tool to measure hemoglobin in retinal arteries. Healthy volunteers from the eye clinic and pregnant otherwise healthy patients of the gynecological department of the Triemli Hospital, Zurich, as well as anemic gynecological patients that show up for a check-up are included.

Hemoglobin will be quantified by a blood draw of a cubital vein. Using a Fundus Camera (Nidek AFC-230) pictures of the fundus will be taken from each study patient. Afterwards the study investigator selects a retinal artery of interest which will be used for measuring the hemoglobin concentration. Intensity of the green channel of the camera chip is determined with the aid of the law of Lambert-Beer.

Absolute Hemoglobin concentration is calculated in relation to the vessel volume.

02

Conditions studied

  • Healthy Subjects
  • Anemia

Keywords

  • retinal hemoglobin concentration
  • non-invasive hemoglobin measurement
03

In context

Lead sponsor

Triemli Hospital is the lead sponsor of 12 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

healthy subjects from the eye clinic of Triemli Hospital anemic and pregnant patients from the gynecology department, Triemli Hospital

Inclusion criteria

  • healthy volunteers
  • pregnant patients from the Triemli Hospital that came for a routine check up
  • anemic patients of the same dept with various gynecological tumors

Exclusion criteria

Exclusion Criteria:

  • any known retinal eye disease
  • poor fundus picture quality due to fixtion problems or too small pupil or media intransparency
  • not willing to participate in a study
05

Study design

Enrollment
100 participants (estimated)

Groups and cohorts

  • healthy volunteers, anemic patients

    healthy volunteers from the eye and gynecology department pregnant patients with anemia

    Device: Fundus photography, cubital blood draw

Interventions

  • DeviceFundus photography, cubital blood draw

    blood draw from a cubital vein to measure hemoglobin concentration taking a fundus photography with a Nidek AFC-230, no pupil dilation needed

06

What researchers measure

Primary outcomes

  1. Correlation of hemoglobin concentration measured in a cubital vein and in a non invasive way using hemoglobinometry in the retinal veins

    Time frame: 2.5 years

07

Study locations

1 of 1 sites recruiting
  • Stadtpital Zürich, Triemli Hospital
    Zürich, 8063, Switzerland
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 3, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01025011
Lead sponsor
Triemli Hospital
First posted
Dec 3, 2009
Start date
Mar 2008
Primary completion
Jun 2010 (estimated)
Completion
Jun 2010 (estimated)
Last update
Dec 3, 2009

Study contacts

Yves Robert, Prof MD
Contact
yves.robert@triemli.stzh.ch
+41 44 466 ext. 3200
Yves Robert, Prof MD
principal investigator · Triemli Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion